The Ion has joined the ranks of an international network of hotspots for innovation. Photo courtesy of The Ion

The Ion Houston has a new feather to add to its cap. Rice Management Company's Midtown innovation hub has been recognized on a global scale.

The Global Network of Innovation Districts has added The Ion District to its network of innovation hubs, and the Ion is the first district in Texas to join. Affiliated with the Brookings Institute, the global organization consists of thought leaders and innovation district developers. With the addition of the Ion, there are 22 members in the Global Network, including the Pittsburgh Innovation District, Cortex Innovation Community in Missouri, Tech Central in Sydney, and Knowledge District Zuidas in Amsterdam.

“GIID’s Global Network is utilizing best practices of world-renowned innovation districts to accelerate regional economies. Their focus on placemaking, startup services, and community engagement are some of the critical components that lead to successful districts,” says Bryson Grover, investment manager of real estate development at Rice Management Company, in a news release. “With GIID, we will continue to think creatively about how the built environment and specialized programming can inform future development and allow equitable access to an ever-changing workforce.”

The Ion, a 266,000-square-foot space in the renovated Midtown Sears building, is the anchor of the district, which also includes Greentown Labs. According to the release, the next building is under construction, with three more projects to begin in the next year. Overall, the build-out of the Ion District will deliver three million square feet of development across 16 acres over the next decade.

“The Ion and the Ion District represent a major commitment and investment in the success of Houston as a center of innovation and a foundation of Houston’s economic future. From the very beginning of our planning, we visited innovation hubs and districts around the country and around the world to make sure that we drew on their experiences and best practices,” says Rice President David Leebron in the release. “And by participating in the Global Network now, the Ion District will contribute to and benefit from a global exchange of knowledge among the very best innovation districts, which complements Rice’s broader international engagements and strategies.”

GIID is a nonprofit dedicated to research on and connecting innovation districts in new geographies of innovation, per the release. Headquartered in New York, the organization was founded in 2018 to help position innovation districts as engines of economic development and spur productive, inclusive, and sustainable environments.

“We’re thrilled for The Ion and Ion District to join our network, especially as it commences its next steps on development later this year,” says Julia Wagner, president of GIID, in the release. “Our team has extensive experience working with unique real estate ventures that aim to transform how communities learn, work, and live. We look forward to playing a part in Houston’s transformation, and as we have documented in innovation districts around the world, having a leader like Rice drive the creation of the district is a key ingredient of its continued and growing success.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."